132 related articles for article (PubMed ID: 33042830)
1. KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis.
Lin H; Ma N; Zhao L; Yang G; Cao B
Front Oncol; 2020; 10():535449. PubMed ID: 33042830
[TBL] [Abstract][Full Text] [Related]
2. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.
Lin H; Yang G; Yu J; Wang J; Li Q; Guo S; Cao B
Biomed Pharmacother; 2018 Nov; 107():1205-1209. PubMed ID: 30257334
[TBL] [Abstract][Full Text] [Related]
3. Regulation of KDM5C stability and enhancer reprogramming in breast cancer.
Xiao Q; Wang CY; Gao C; Chen JD; Chen JJ; Wang Z; Ju LG; Tang SB; Yao J; Li F; Li LY; Wu M
Cell Death Dis; 2022 Oct; 13(10):843. PubMed ID: 36192394
[TBL] [Abstract][Full Text] [Related]
4. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
[TBL] [Abstract][Full Text] [Related]
5. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
6. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation.
Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H
Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580
[TBL] [Abstract][Full Text] [Related]
7. N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor.
Fiore D; Piscopo C; Proto MC; Vasaturo M; Dal Piaz F; Fusco BM; Pagano C; Laezza C; Bifulco M; Gazzerro P
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569395
[TBL] [Abstract][Full Text] [Related]
8. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
[TBL] [Abstract][Full Text] [Related]
9. E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter.
Liu KL; Yin YW; Lu BS; Niu YL; Wang DD; Shi B; Zhang H; Guo PY; Yang Z; Li W
Cancer Cell Int; 2022 Mar; 22(1):109. PubMed ID: 35248043
[TBL] [Abstract][Full Text] [Related]
10. FBXW7 in Cancer: What Has Been Unraveled Thus Far?
Sailo BL; Banik K; Girisa S; Bordoloi D; Fan L; Halim CE; Wang H; Kumar AP; Zheng D; Mao X; Sethi G; Kunnumakkara AB
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30791487
[No Abstract] [Full Text] [Related]
11. KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma.
Zhang B; Zhou BH; Xiao M; Li H; Guo L; Wang MX; Yu SH; Ye QH
Front Oncol; 2020; 10():1025. PubMed ID: 32714863
[No Abstract] [Full Text] [Related]
12. Sensitization of colon cancer cells to cisplatin by Fbxw7 via negative regulation of the Nox1-mTOR pathway.
Huang G; Long K
Pathol Res Pract; 2023 Jul; 247():154479. PubMed ID: 37262995
[TBL] [Abstract][Full Text] [Related]
13. FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.
Hagedorn M; Delugin M; Abraldes I; Allain N; Belaud-Rotureau MA; Turmo M; Prigent C; Loiseau H; Bikfalvi A; Javerzat S
Cell Div; 2007 Feb; 2():9. PubMed ID: 17326833
[TBL] [Abstract][Full Text] [Related]
14. Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function.
Outchkourov NS; Muiño JM; Kaufmann K; van Ijcken WF; Groot Koerkamp MJ; van Leenen D; de Graaf P; Holstege FC; Grosveld FG; Timmers HT
Cell Rep; 2013 Apr; 3(4):1071-9. PubMed ID: 23545502
[TBL] [Abstract][Full Text] [Related]
15. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
16. MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.
Chang H; Liu YH; Wang LL; Wang J; Zhao ZH; Qu JF; Wang SF
Am J Transl Res; 2018; 10(4):1131-1142. PubMed ID: 29736206
[TBL] [Abstract][Full Text] [Related]
17. Low expression of the ubiquitin ligase FBXW7 correlates with poor prognosis of patients with colorectal cancer.
Liu H; Wang K; Fu H; Song J
Int J Clin Exp Pathol; 2018; 11(1):413-419. PubMed ID: 31938126
[TBL] [Abstract][Full Text] [Related]
18. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
19. LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity.
Lan H; Tan M; Zhang Q; Yang F; Wang S; Li H; Xiong X; Sun Y
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12311-12320. PubMed ID: 31152129
[TBL] [Abstract][Full Text] [Related]
20. Elevated histone demethylase KDM5C increases recurrent miscarriage risk by preventing trophoblast proliferation and invasion.
Xiao M; Zheng Y; Wang MX; Sun YH; Chen J; Zhu KY; Zhang F; Tang YH; Yang F; Zhou T; Zhang YP; Lei CX; Sun XX; Yu SH; Tian FJ
Cell Death Discov; 2022 Dec; 8(1):495. PubMed ID: 36550096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]